Actively Recruiting
Heparin vs Placebo for Cardiac Catheterization
Led by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Updated on 2026-02-20
1623
Participants Needed
2
Research Sites
321 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patients undergoing cardiac catheterization will be randomized to 3 groups: no anticoagulant, low dose anticoagulant and high dose anticoagulant.
CONDITIONS
Official Title
Heparin vs Placebo for Cardiac Catheterization
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Undergoing diagnostic cardiac catheterization
- Use of a small size sheath
- Normal patency of the ulno-palmar circulation
You will not qualify if you...
- Abnormal ulno-palmar circulation
- Prior radial artery thrombosis
- Prior surgery near the catheterization access site
- Emergent cardiac catheterization
- History of heparin-induced thrombocytopenia or allergy to heparin
- Patients requiring anticoagulation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Hamilton Health Sciences
Hamilton, Ontario, Canada
Actively Recruiting
2
London Health Sciences Centre
London, Ontario, Canada, N6A5A5
Actively Recruiting
Research Team
S
Shahar Lavi, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here